
An Integrated Solution for Acute Respiratory Failure
The HEMOLUNG® removes carbon dioxide directly from the blood,
allowing the lungs to rest and heal.

FDA Grants HEMOLUNG®
De Novo Clearance
The first and only FDA cleared
extracorporeal CO2 removal (ECCO2R) device.

Clinical Benefits
HEMOLUNG® therapy corrects hypercapnia and respiratory acidosis which can enable avoidance or de-escalation of invasive mechanical ventilation.